GL1X · GenesisL1 explorer

MolNFT v1 · #61262 · protein

Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6

3DGD: “Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6”. X-ray diffraction, 1 ligand (ZN), 6 pockets (best druggability 0.58). MolNFT v1 #61262 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3DGD
Type
protein
Length
462 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
ZN
Pockets
6 · best druggability 0.58

Structure

x-ray diffraction · 2 distinct chains · 0% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CTransthyretinprotein1160% helix, 52% strandP02766
B, DTransthyretinprotein1150% helix, 52% strandP02766

Ligands and binding sites

  • ZN · Zinc ion · metal · 15 copies · chains A, B, C, D
  • ACT · Acetate ion · additive · 12 copies · chains A, B, C, D
  • GOL · Glycerol · additive · 3 copies · chains B, A, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12410.580.7933empty
22460.580.7937empty
31740.520.7826ACT, ZN, GOL
4860.360.7623empty
5640.340.7719empty

Interfaces

6 interfaces between chains.

  • A–B · 875 Ų buried · 20 hydrogen bonds · protein-protein
  • C–D · 850 Ų buried · 15 hydrogen bonds · protein-protein
  • B–D · 470 Ų buried · 3 hydrogen bonds · protein-protein
  • B–C · 440 Ų buried · 4 hydrogen bonds · protein-protein
  • A–C · 438 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 3DGD · Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.